196 related articles for article (PubMed ID: 29802788)
1. Treatment with non-selective beta-blockers affects the systemic inflammatory response to bacterial DNA in patients with cirrhosis.
Gimenez P; Garcia-Martinez I; Francés R; Gonzalez-Navajas JM; Mauri M; Alfayate R; Almenara S; Miralles C; Palazon JM; Carnicer F; Pascual S; Such J; Horga JF; Zapater P
Liver Int; 2018 Dec; 38(12):2219-2227. PubMed ID: 29802788
[TBL] [Abstract][Full Text] [Related]
2. Grade of soluble inflammatory response is mainly affected by circulating bacterial DNA concentrations in cirrhosis.
Caro E; Francés R; Zapater P; Pascual S; Bellot P; Such J
Liver Int; 2016 Oct; 36(10):1473-80. PubMed ID: 26991936
[TBL] [Abstract][Full Text] [Related]
3. Development of ascites in compensated cirrhosis with severe portal hypertension treated with β-blockers.
Hernández-Gea V; Aracil C; Colomo A; Garupera I; Poca M; Torras X; Miñana J; Guarner C; Villanueva C
Am J Gastroenterol; 2012 Mar; 107(3):418-27. PubMed ID: 22334252
[TBL] [Abstract][Full Text] [Related]
4. The detection of bacterial DNA in blood of rats with CCl4-induced cirrhosis with ascites represents episodes of bacterial translocation.
Guarner C; González-Navajas JM; Sánchez E; Soriando G; Francés R; Chiva M; Zapater P; Benlloch S; Muñoz C; Pascual S; Balanzó J; Pérez-Mateo M; Such J
Hepatology; 2006 Sep; 44(3):633-9. PubMed ID: 16941689
[TBL] [Abstract][Full Text] [Related]
5. Use of proton pump inhibitors decrease cellular oxidative burst in patients with decompensated cirrhosis.
Garcia-Martinez I; Francés R; Zapater P; Giménez P; Gómez-Hurtado I; Moratalla A; Lozano-Ruiz B; Bellot P; González-Navajas JM; Such J
J Gastroenterol Hepatol; 2015 Jan; 30(1):147-54. PubMed ID: 25039465
[TBL] [Abstract][Full Text] [Related]
6. Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis: a pilot study.
Thalheimer U; De Iorio F; Capra F; del Mar Lleo M; Zuliani V; Ghidini V; Tafi MC; Caburlotto G; Gennari M; Burroughs AK; Vantini I
Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1228-34. PubMed ID: 20512041
[TBL] [Abstract][Full Text] [Related]
7. Editorial: Beta-blockers and the prevention of decompensation in cirrhosis: worth the trouble.
Northup PG; Henry ZH
Am J Gastroenterol; 2012 Mar; 107(3):428-30. PubMed ID: 22388023
[TBL] [Abstract][Full Text] [Related]
8. Translocation of bacterial DNA from Gram-positive microorganisms is associated with a species-specific inflammatory response in serum and ascitic fluid of patients with cirrhosis.
Francés R; González-Navajas JM; Zapater P; Muñoz C; Caño R; Pascual S; Santana F; Márquez D; Pérez-Mateo M; Such J
Clin Exp Immunol; 2007 Nov; 150(2):230-7. PubMed ID: 17822441
[TBL] [Abstract][Full Text] [Related]
9. Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis.
Zapater P; Francés R; González-Navajas JM; de la Hoz MA; Moreu R; Pascual S; Monfort D; Montoliu S; Vila C; Escudero A; Torras X; Cirera I; Llanos L; Guarner-Argente C; Palazón JM; Carnicer F; Bellot P; Guarner C; Planas R; Solá R; Serra MA; Muñoz C; Pérez-Mateo M; Such J
Hepatology; 2008 Dec; 48(6):1924-31. PubMed ID: 19003911
[TBL] [Abstract][Full Text] [Related]
10. Intracellular cytokine expression in peritoneal monocyte/macrophages obtained from patients with cirrhosis and presence of bacterial DNA.
Francés R; Rodríguez E; Muñoz C; Zapater P; De la ML; Ndongo M; Pérez-Mateo M; Such J
Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):45-51. PubMed ID: 15647640
[TBL] [Abstract][Full Text] [Related]
11. Beta adrenergic blockade and decompensated cirrhosis.
Reiberger T; Mandorfer M
J Hepatol; 2017 Apr; 66(4):849-859. PubMed ID: 27864004
[TBL] [Abstract][Full Text] [Related]
12. Proteomic evidence of bacterial peptide translocation in afebrile patients with cirrhosis and ascites.
Caño R; Llanos L; Zapater P; Pascual S; Bellot P; Barquero C; Pérez-Mateo M; Such J; Francés R
J Mol Med (Berl); 2010 May; 88(5):487-95. PubMed ID: 20087563
[TBL] [Abstract][Full Text] [Related]
13. Functionality of beta-adrenergic receptors in patients with cirrhosis treated chronically with non-selective beta-blockers.
Almenara S; Lozano B; Gimenez P; Herrera I; Miralles C; Bellot P; Rodríguez M; Francés R; Gonzalez-Navajas JM; Pascual S; Zapater P
Hepatol Int; 2020 Sep; 14(5):858-868. PubMed ID: 32885366
[TBL] [Abstract][Full Text] [Related]
14. Use of non-selective beta blockers in cirrhosis: the evidence we need before closing (or not) the window.
La Mura V; Tosetti G; Primignani M; Salerno F
World J Gastroenterol; 2015 Feb; 21(8):2265-8. PubMed ID: 25741132
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of bacterial DNA in patients with decompensated cirrhosis and suspected infection.
Bruns T; Reuken PA; Stengel S; Gerber L; Appenrodt B; Schade JH; Lammert F; Zeuzem S; Stallmach A
Liver Int; 2016 Aug; 36(8):1133-42. PubMed ID: 26901072
[TBL] [Abstract][Full Text] [Related]
16. Norfloxacin modulates the inflammatory response and directly affects neutrophils in patients with decompensated cirrhosis.
Zapater P; Caño R; Llanos L; Ruiz-Alcaraz AJ; Pascual S; Barquero C; Moreu R; Bellot P; Horga JF; Muñoz C; Pérez J; García-Peñarrubia P; Pérez-Mateo M; Such J; Francés R
Gastroenterology; 2009 Nov; 137(5):1669-79.e1. PubMed ID: 19660462
[TBL] [Abstract][Full Text] [Related]
17. Systemic arterial blood pressure determines the therapeutic window of non-selective beta blockers in decompensated cirrhosis.
Tergast TL; Kimmann M; Laser H; Gerbel S; Manns MP; Cornberg M; Maasoumy B
Aliment Pharmacol Ther; 2019 Sep; 50(6):696-706. PubMed ID: 31373713
[TBL] [Abstract][Full Text] [Related]
18. Beta-blockers in cirrhosis and refractory ascites: a retrospective cohort study and review of the literature.
Kimer N; Feineis M; Møller S; Bendtsen F
Scand J Gastroenterol; 2015 Feb; 50(2):129-37. PubMed ID: 25113796
[TBL] [Abstract][Full Text] [Related]
19. Beta-blockers in portal hypertension: new developments and controversies.
Tripathi D; Hayes PC
Liver Int; 2014 May; 34(5):655-67. PubMed ID: 24134058
[TBL] [Abstract][Full Text] [Related]
20. Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites.
Francés R; Muñoz C; Zapater P; Uceda F; Gascón I; Pascual S; Pérez-Mateo M; Such J
Gut; 2004 Jun; 53(6):860-4. PubMed ID: 15138214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
